Page 34 - Use Authorization News Today

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).

Louisiana has very limited number of pills available at independent pharmacies

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older •First emergency use... | January 3, 2022

<strong>SPECIAL FEATURE</strong> | This year will go down in history as one of the biggest dumpster fires of all time.

The infusion centers will not be able to offer Sotrovimab until federal authorities ship more supplies in January

The U.S. Food and Drug Administration recently issued an Emergency Use Authorization for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets) - the first oral treatment for COVID-19.

The Louisiana Department of Health announced Thursday it has a very limited supply of a COVID-19 treatment pill.

The Food and Drug Administration (FDA) this week authorized a new, quick at-home COVID-19 test produced by Siemens ...

The Indian equity indices -- S&P BSE Sensex and NSE Nifty50 -- settled marginally higher on Wednesday.

No news is bad news for the beaten-down stock.